Innovate UK launches £5m competition to scale up genomic analysis technologies
[London, UK] Innovate UK is investing up to £5m in projects aiming to expand the UK’s ability to carry out genomic analysis.
Genomic analysis can improve understanding and treatment of diseases such as diabetes and cancer.
Funded through the government’s £210m from data to early diagnosis and precision medicine challenge, the new competition is aimed at businesses whose total project costs would add up to a maximum of £10m, with an estimated delivery period of up to five months - starting in October this year.
Innovate UK says it will support investment in equipment to help create new tools and services to diagnose diseases earlier.
But the technology would have to be a 'significant step-change' over existing platforms, offering ‘disruptive market potential’.
To obtain a share of the funding, applicants also need to prove that their projects could advance the UK’s capacity to manufacture and commercialise genomic analysis technologies, fostering collaboration between public and private organisations.
The competition will not fund genomics discovery or genome sequencing and other ‘omics analysis projects.
Innovate UK is organising an online briefing event on June 22. The competition will close on July 18.